UCSF enrolling patients for trial testing immunotherapy treatment for cancer
University of California San Francisco
Give to UCSF
Displaying 16261 - 16290 of 16393
-
-
UCSF Audiology Clinic offers world's first disposable hearing aids
-
UCSF finding suggests mechanism of experimental cancer drug, hinting at broader application for the
University of California San Francisco researchers may have discovered why the experimental anti-cancer drug Onyx-015 works more broadly than had been expected...
-
CPR training for parents of high-risk neonates improves family adjustment at home
Cardiopulmonary (CPR) training can relieve stress for parents and improve survival outcomes for infants at high risk for cardiopulmonary arrest, a new study has found.
-
Scientists develop chemical switch for natural signaling molecules, opening new approach to biomedic
A team led by a University of California, San Francisco scientist has developed drug-like inhibitors to study vital signaling molecules essential for almost all cell activity.
-
Prominent immunologist and leader in diabetes research joins UCSF study
Jeffrey A. Bluestone, PhD, one of the world's leading experts on why the body's immune system rejects or tolerates transplanted tissue, has been appointed to a new professorship at the University of California, San Francisco devoted to diabetes research.
-
Massive new research effort will map inner workings of cells - San Francisco VA Medical Center chose
A new $50 million dollar research program launched this month will begin the daunting task of mapping out the thousands of molecular interactions that cells use in responding to their environment.
-
NIH awards grant to UCSF and Kaiser to strengthen women's health research
-
UCSF study points to new dilemmas confronting HIV healthcare providers
The new optimism expressed by healthcare providers treating HIV seropositive patients is mitigated by concerns surrounding treatment decisions and skepticism about the future according to a new University of California, San Francisco study.
-
Most minorities don't reap benefits of California's strong labor market, according to UCSF researche
While California's labor market continues to be strong, Latinos and African Americans - who together make up 31 percent of California's working population - are being left behind by the state's technology-driven economic boom...
-
California labor market is strong, but workers in poor health don't benefit, UCSF study reports
Results of the 2000 California Work and Health Survey (CWHS) indicate high employment rates among all working age Californians, long hours of work and large numbers of workers who report promotions, new and better jobs and increased earnings.
-
Women's natural estrogen levels help protect against cognitive decline, UCSF/VA study says
Older women with high estrogen levels are less likely to suffer cognitive decline, says a new study from researchers at the University of California, San Francisco and the San Francisco Veterans Affairs Medical Center.
-
University of California, San Francisco psychiatrist's new book offers inside look into the sex live
Sexuality is both an important and confusing part of adolescence. It is also a subject parents and others often do not want to talk about-sometimes going so far as to deny that teenagers have sexual lives.
-
UCSF School of Medicine develops innovative new curriculum
-
Emergency contraception is used when needed but doesn't increase high-risk sex, according to UCSF st
Young women who have an advance provision of emergency contraception are more likely to use it when they need it, but its availability does not appear to increase risky sexual behavior, according to a new study by University of California, San Francisco researchers.
-
UCSF study finds increased risk of incontinence in women who have hysterectomy
Women who have undergone a hysterectomy have a substantially higher risk of developing urinary incontinence later in life compared to women who have not had a hysterectomy, according to a University of California, San Francisco study.
-
UCSF researchers identify regulator of critical brain messenger, hinting at therapy
UCSF researchers have identified the protein that transports the chemical signal to the neurotransmitter glutamate's launch site in nerve cells, offering a possible new target for treating such diseases as Alzheimer's disease.
-
New health tech job training program addresses needs of low-income San Franciscans in Visitacion Valley
-
UCSF advocate to climb Mt. Fuji to promote breast cancer research
-
Surgeon General David Satcher, MD, PhD, to give keynote address at launch of UCSF Center for Health
-
UCSF Medical Center offers screening test for early detection of lung cancer
-
Study finds women screened for cervical cancer one, two and three years after normal test results ha
Women who undergo Pap smear tests to screen for cervical cancer one, two or three years after having had normal test results had about the same low rate of significant cellular abnormalities, a University of California, San Francisco study has found.
-
UCSF scientists report first direct demonstration that deformed prion protein shape alone causes inf
Scientists have shown for the first time that pure prion proteins can trigger normal proteins to change shape and become infectious.
-
UCSF School of Dentistry Center grant funds research to prevent childhood tooth decay
-
Triglyceride measurements no help in predicting heart disease in men, study finds
Measuring the levels of triglyceride fats in the blood does not aid in the prediction of heart disease in men, according to new research from the San Francisco Veterans Affairs Medical Center (VAMC) and the University of California, San Francisco.
-
Program that provides family planning services to low income residents helps reduce rate of unintend
-
Insured minorties continue to face obstacles to heatlh care, UCSF study reports
Minorities, particularly Hispanics and Asian Americans, are more likely than non-Hispanic whites to report obstacles in access to health care, according to a University of California, San Francisco study.
-
Research shows savings can be achieved in Ugandan company provides HIV drugs to employees
-
Marijuana Does Not Appear to Alter Viral Loads of HIV Patients Taking Protease Inhibitors
A study by researchers from the University of California, San Francisco has found that patients with HIV infection taking protease inhibitors do not experience short-term adverse virologic effects from using cannabinoids.
-
HIV increasing at Brazilian test site, with evidence of transmission of resistant virus
University of California, San Francisco researchers and Brazilian colleagues report that analysis of blood samples taken at an anonymous test site in Santos, Brazil from 1995 to 1999 show an increase in the rate of HIV infection after a period of decline.